Shanshan Suo

机构：Zhejiang Technical Institute of Economics, First Affiliated Hospital Zhejiang University, Xi'an Jiaotong University

发表论文 55 篇 · 总被引 597 次 · h-index 13

代表论文

• Molecular remission uncoupled with complete haematological response in polycythaemia vera treatment with ropeginterferon alfa‐2b (2024 · British Journal of Haematology · 被引 17)
• Homoharringtonine inhibits the NOTCH/MYC pathway and exhibits antitumor effects in T-cell acute lymphoblastic leukemia (2024 · Blood · 被引 17)
• Homoharringtonine synergizes with venetoclax in early T cell progenitor acute lymphoblastic leukemia: Bench and bed (2024 · Med · 被引 13)
• Population Pharmacokinetics‐Pharmacodynamics and Exposure‐Response of Ropeginterferon Alfa‐2b in Chinese and Japanese Patients With Polycythemia Vera (2025 · Pharmacology Research & Perspectives · 被引 9)
• Ropeginterferon alfa-2b shows anti-polycythaemia vera activity without causing clinically significant anaemia (2024 · BJC Reports · 被引 7)
• Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study (2024 · Blood Cancer Journal · 被引 5)